Services

Dr. Yanshan Wang is an institutional and national leader in healthcare artificial intelligence, clinical informatics, and translational data science. His leadership focuses on building scalable AI infrastructure, advancing generative AI adoption in healthcare, and developing research ecosystems that accelerate data-driven discovery.

Across his roles at the University of Pittsburgh and national research organizations, he leads initiatives spanning research strategy, enterprise AI platforms, national scientific collaborations, and workforce development in healthcare AI.

Institutional Leadership

Vice Chair of Research

Department of Health Informatics — University of Pittsburgh

As Vice Chair of Research, Dr. Wang leads the strategic growth of the department's research enterprise, focusing on expanding federally funded research, strengthening interdisciplinary collaboration, and positioning the department as a national leader in AI-driven health informatics.

His leadership spans research portfolio strategy, faculty development, funding growth, and research infrastructure development.

Key Outcomes

  • Departmental research expenditures increased 3–4 fold
  • Pending research funding increased approximately six-fold
  • Faculty participation in major grant programs expanded significantly
  • Cross-school collaborations increased across clinical, engineering, and data science programs

His leadership model emphasizes building sustainable research ecosystems combining AI innovation, translational science, and workforce development.

AI and Data Infrastructure Leadership

Director of AI

Clinical and Translational Science Institute (CTSI), University of Pittsburgh

Dr. Wang leads institutional AI strategy within the CTSI, developing an AI-as-a-Service model that enables investigators to access advanced AI capabilities without requiring dedicated technical teams.

Team Capabilities

  • Clinical data science support
  • Machine learning and deep learning development
  • Natural language processing solutions
  • Large language model and generative AI implementation
  • AI evaluation and deployment frameworks
  • Research computing consulting

His work focuses on lowering barriers to AI adoption and enabling investigators to integrate advanced computational methods into translational research.

Director of Generative AI

Computational Pathology & AI Center of Excellence (CPACE)

At CPACE, Dr. Wang leads the development and translation of generative AI technologies into clinical diagnostic domains, particularly pathology and laboratory medicine.

Focus Areas

  • Development of clinical LLM applications
  • Multimodal AI integration into diagnostic workflows
  • Responsible AI deployment strategies
  • Cross-disciplinary AI research coordination
  • Institutional strategy for foundation model adoption

His leadership helps position Pitt among early adopters of clinical generative AI technologies.

Founder and Director

ReDWINE Research Data Platform

Dr. Wang founded and leads ReDWINE (Rehabilitation Data Warehouse & Informatics Environment), an institutional research data platform supporting rehabilitation and clinical outcomes research.

Platform Capabilities

  • Standardized electronic health record datasets
  • Research-ready clinical data pipelines
  • Secure data governance frameworks
  • Analytical tools supporting data science workflows
  • AI-ready datasets supporting machine learning research

Through ReDWINE, Dr. Wang established critical research infrastructure supporting data-intensive rehabilitation science and enabling scalable AI research programs.

Community and Ecosystem Leadership

Founder and Chair

Pitt/UPMC Generative AI and LLM Interest Group

Recognizing the need for coordinated AI strategy across research and healthcare operations, Dr. Wang founded the Pitt/UPMC Generative AI and LLM Interest Group. This community brings together more than 50 stakeholders including clinicians, researchers, informaticians, and health system leadership.

Group Activities

  • Institutional AI strategy discussions
  • Knowledge sharing on LLM technologies
  • Educational programming in generative AI
  • Cross-institution collaboration development
  • Responsible AI adoption discussions

This initiative contributes to regional leadership in healthcare AI innovation.

National Leadership

Lead, NLP Working Group

ENACT National Research Network

Dr. Wang leads national efforts advancing natural language processing methods within the ENACT network, supporting scalable clinical research across multiple institutions.

Focus Areas

  • NLP methods for multi-site research
  • Clinical text phenotyping infrastructure
  • Standards for reproducible AI research
  • Collaboration between informatics centers
  • AI methods for large-scale clinical data networks

This work supports national infrastructure enabling next-generation clinical AI research.

Past Chair

AMIA Natural Language Processing Working Group

As Past Chair of the AMIA NLP Working Group, Dr. Wang helped shape one of the largest biomedical NLP communities globally.

Contributions

  • Scientific program development
  • Community expansion initiatives
  • Trainee mentorship programs
  • Industry–academic collaboration development
  • Early leadership in LLM adoption discussions

His service reflects sustained national influence in biomedical AI research.